Today, China New Pharmaceutical opened at 17.4 yuan. As of 10:55 points, the stock rose 10% to 19.25 yuan, closing the daily limit. The company is mainly engaged in the production and sales of traditional Chinese medicine, chemical medicine and bioengineering drugs.

2025/06/2820:26:34 hotcomm 1978

Financial World Website reported on June 17 that , China New Pharmaceutical opened at 17.4 yuan. As of 10:55, the stock rose 10% to 19.25 yuan, blocking the daily limit.

Yesterday (2020-06-16), the net inflow of the stock was 9.5757 million yuan, the main force was 9.9399 million yuan, the net outflow of the mid-select was 5,599 yuan, and the net outflow of retail investors was 358,600 yuan.

In the past month, Zhongxin Pharmaceutical has been on the Dragon and Tiger List 0 times, indicating that Zhongxin Pharmaceutical is not active.

Company is mainly engaged in the production and sales of traditional Chinese medicine, chemical drugs, and bioengineering drugs. As of March 31, 2020, China New Pharmaceutical 's operating income was 1.65596 billion yuan, and the net profit attributable to the parent company's shareholders was 16989 million yuan, a decrease of 10.5876% year-on-year, and basic earnings per share was 0.221 yuan.

Risk warning: The individual stock diagnostic results are produced by processing objective data through operational models. They are for reference only and do not constitute absolute investment advice.

hotcomm

Although Americans generally received fiscal stimulus checks at the beginning of the year and personal spending also stopped falling for two months, the rise in income and expenditure did not bring significant inflationary pressure. According to statistics from the U.S. Departmen

Fed's favoured inflation indicators: Nominal and core PCE price indexes are well below 2% in January, but hit a record high of at least four months

06/28 1869

On September 30, local time, the U.S. Department of Commerce released data showing that the U.S. personal consumption expenditure price index rose by 0.3% month-on-month and 6.2% year-on-year, indicating that the U.S. inflation situation still shows signs of worsening, and the Fe

North America Observation丨Personal Consumer Expenditure Price Index Bounces, U.S. Inflation Still Deteriorates

06/28 1772

The latest data released by the U.S. Department of Commerce on September 30 local time showed that the U.S. personal consumption expenditure price index rose by 0.3% month-on-month and 6.2% year-on-year, and the year-on-year increase has been above 6% for eight consecutive months

The U.S. move is "aggressive" to global economic growth

06/28 1202

The U.S. GDP data in the first quarter of this year reached 3.2%, the highest since the third quarter of 2018. On Tuesday, he tweeted to the Fed: “Not only should we restart quantitative loosening, but we should also lower interest rates by 1%.

"As long as interest rate cuts by 1%, restarts QE, the US economy will take the Rockets"

06/28 1749

Zhitong Finance APP learned that the latest data released by the U.S. Department of Commerce on Thursday showed that the price-adjusted spending on goods and services (actual personal consumption expenditure) in May was revised down to a month-on-month decline of 0.4%, and a mont

Fed's favorite inflation indicators continue to cool down, but consumer spending continues to slow down

06/28 1318

On September 30, data from the US Department of Commerce showed that the US PCE price index in August increased by 6.2% year-on-year, 6% higher than market expectations, and the previous value was 6.3%;

The inflation indicator that the Federal Reserve attaches most attention to unexpectedly accelerates its upward trend! Core PCE increased by 4.9% year-on-year in August

06/28 1909